Overview
Work History
Education
Publications
Poster presentations
TEST SCORES
Timeline
Generic

Dhara P. Popat

Shreveport,LA

Overview

5
5
years of professional experience

Work History

Resident

Louisiana State University Health Shreveport
07.2024 - Current
  • Internal Medicine Residency

Intern

Bayhealth Medical Center
07.2023 - 06.2024
  • Internal Medicine Residency

Medical Student Clerkship

Civil Hospital
03.2020 - 03.2021

Acting Intern

Cleveland Clinic
02.2020 - 03.2020

Education

Bachelor of Medicine and Bachelor of Surgery - M.B.B.S.

B.J Medical College, Gujarat University
Ahmedabad, Gujarat, India
08.2021

Publications

Journal Publications (published)


1. Aldakkour JL, Devarkonda V, Popat D, Hammoud D. Assessing oncology fellows' insights to enhance cancer care: A quality improvement initiative. J Clin Oncol. 2025;43(16_suppl): e23241. 

 doi:10.1200/JCO.2025.43.16_suppl.e23241  


2. Jain S, Popat D, Jain H, Vashi M, Gadhiya R, Viramgama FR, Jamal A, Kalra S, Koyani HB, Desai H, Amin V. Global burden of prostate cancer in 38 OECD countries and its trend from 1990–2021: An insight from the Global Burden of Disease study 2021. J Clin Oncol. 2025;43(16_suppl): e17005. 

doi:10.1200/JCO.2025.43.16_suppl.e17005


3. Chandra MB, Modi S, Popat D, Jain S, Giri T, Jindal M, Koyani HB, Amin V, Desai H. Mapping the burden of uterine cancer in the EU from 1990–2021: Global and national disparities, age trends, and implications for public health. J Clin Oncol. 2025;43(16_suppl): e17639. 

doi:10.1200/JCO.2025.43.16_suppl.e17639


4. Viramgama FR, Popat D, Verma J, Shah R, Jindal M, Khan HM, Jain S, Syed S, Jamal A, Aleem A, Koyani HB, Desai H. Burden of tracheal, bronchus, and lung cancer in high-income North America: Trends from 1990 to 2021 and death projections to 2050. J Clin Oncol. 2025;43(16_suppl): e22519. 

 doi:10.1200/JCO.2025.43.16_suppl.e22519 


5. Singh A, Sanghavi N, Popat D, Bandari V, Alfaraj A. Complete remission of high-risk myelodysplastic syndrome with combination therapy. Clin Lymphoma Myeloma Leuk. September 2024;24 (Supplement 1): S385–S386. Pub status: Published

doi: 10.1016/S2152-2650(24)01343-0 


Journal Publications (other than published)


1. Popat D, Gadhiya D, Nanna S, Savani K, Singla R. Rising mortality due to non-Hodgkin lymphoma among adults in the United States. Clinical, Lymphoma, Myeloma, & Leukemia, SOHO 2025 supplement Pub status: Accepted


2. Popat D, Gadhiya D, Nanna S, Savani K, Bai M, Jeurkar R, Patel DS, Dhillon BK, Ramphul K, Chennapragada S. Differences in demographic characteristics between male and female non-Hodgkin lymphoma survivors admitted with colorectal cancer in the United States. Clinical, Lymphoma, Myeloma, & Leukemia, SOHO 2025 supplement Pub status: Accepted


3. Popat D, Nanna S, Gadhiya D, Savani K, Bai M, Jeurkar R, Patel DS, Sanepara A, Ramphul K, Chennapragada S. Analyzing the outcomes of adults with diffuse large B-cell lymphoma following admission for non-ST-elevation myocardial infarction. Clinical, Lymphoma, Myeloma, & Leukemia, SOHO 2025 supplement Pub status: Accepted


4. Popat D, Gadhiya D, Nanna S, Savani K, Bai M, Jeurkar R, Patel DS, Kalra HS, Ramphul K, Chennapragada S. Sex-based differences in demographics and outcomes of active chronic lymphocytic leukemia patients admitted for bloodstream infection due to central venous catheter. SOHO 2025 Annual Meeting. Pub status: under review


5. Popat D, Jain S, Ramadas P. Enhancing Sickle Cell Pain Management Practices among Medicine Residents: A Quality Improvement Initiative. ASH 2025 Annual Meeting Pub status: submitted


6. Popat D, Jain S, Gaddam SJ, Ramadas P Luspaterecept: From Bench to Bedside and Beyond in the Management of Ineffective Erythropoiesis. Critical reviews in Onoclogy/Hematology. May 2025 Pub status: submitted


7. Popat D, Jain S, Gaddam SJ, Ramadas P, Fan X. EPO refractory anemia in secondary myelofibrosis responds remarkably to Luspaterecept. The American Journal of Case Reports. April 2025 Pub status: under review


8. Popat D, Jain S, Gaddam SJ, Ramadas P. Philadelphia chromosome positive mixed phenotype acute leukemia: Targeted therapy as an alternative to chemotherapy. The American Journal of Case Reports. April 2025 Pub status: under review


9. Anvekar P, Popat D, Gaddam SJ, Arora KS, Devarashetty S. The unusual case of extraosseous Ewing’s sarcoma diagnosed from a pulmonary embolus. Cancer reports. April 2025. Pub status: under review

Poster presentations

1. Popat D, Gadhiya D, Nanna S, Bai M, Jeurkar R, Chilakuluri P, Ramphul K, Chennapragada S. Poster accepted: Mortality rates and risk factors among neutropenic active acute myeloid leukemia patients with invasive pulmonary aspergillosis: A retrospective analysis from the United States. Society of Hematologic Oncology, Houston, TX. September 2025


2. Popat D, Nanna S, Gadhiya D, Bai M, Jeurkar R, Chilakuluri P, Ramphul K, Chennapragada S. Poster accepted: Outcomes of acute myeloid leukemia in remission following admission for influenza in the United States: A propensity-matched analysis. Society of Hematologic Oncology, Houston, TX. September 2025


3. Popat D, Gadhiya D, Nanna S, Bai M, Jeurkar R, Chilakuluri P, Ramphul K, Chennapragada S. Poster accepted: Investigating unplanned 30-day readmissions among acute myeloid leukemia patients with upper gastrointestinal bleeding in the United States. Society of Hematologic Oncology, Houston, TX. September 2025


4. Popat D, Nanna S, Gadhiya D, Jeurkar R, Bai M, Chilakuluri P, Ramphul K, Chennapragada S. Poster accepted: Demographics, management, and outcomes of active acute myeloid leukemia patients admitted for acute pulmonary embolism: A propensity-score matched study from the United States. Society of Hematologic Oncology, Houston, TX. September 2025


5. Popat D, Jain S, Gaddam SJ, Ramadas P. Poster presented: Targeted Therapy in Mixed Phenotype Acute Leukemia: An Alternative to Chemotherapy? Annual Internal Medicine LSU Research Day, Shreveport, LA. May 2025


6. Popat D, Jain S, Gaddam SJ. Poster presented: Erythropoiesis-Stimulating Agent–Refractory Anemia in Secondary Myelofibrosis Responds Remarkably to Luspaterecept. National American College of Physicians (ACP) Meeting, New Orleans, LA. April 2025


7. Popat D, Singh A, Alfaraj A. Poster presented: Dramatically decreased transfusion dependency with Luspaterecept in a case of high-risk MDS. Society of Hematologic Oncology, Houston, TX. September 2024.

doi:10.1016/S2152-2650(24)01375-2.


8. Popat D, Sanghavi N, Singh A, Sawhney R. Poster presented: Parsonage Turner syndrome complicating multiple myeloma therapy: “Nothing to shrug your shoulders at” Society of Hematologic Oncology, Houston, TX. September 2024

doi:10.1016/S2152-2650(24)01720-8.


9. Popat D, Sanghavi N, Singh A, Sawhney R. Poster presented: Parsonage Turner syndrome complicating multiple myeloma therapy: “Nothing to shrug your shoulders at” Annual Bayhealth Research Day, Dover, DE. May 2024

TEST SCORES

  • USMLE Step 1: 249
  • USMLE Step 2: 252
  • USMLE Step 3: 222

Timeline

Resident

Louisiana State University Health Shreveport
07.2024 - Current

Intern

Bayhealth Medical Center
07.2023 - 06.2024

Medical Student Clerkship

Civil Hospital
03.2020 - 03.2021

Acting Intern

Cleveland Clinic
02.2020 - 03.2020

Bachelor of Medicine and Bachelor of Surgery - M.B.B.S.

B.J Medical College, Gujarat University
Dhara P. Popat